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resumo 
 
 
As nanopartículas de prata têm grande importância pelas suas propriedades 
antimicrobianas sendo cada vez mais usadas, por exemplo, no revestimento 
de próteses, em material médico, no revestimento de embalagens alimentares 
e em cosmética. A sua crescente manufacturação reflectir-se-á também na sua 
existência no meio ambiente, como por exemplo, no ar, expondo o organismo 
aos seus potenciais efeitos prejudiciais. Este trabalho teve como objectivo a 
avaliação dos possíveis efeitos genotóxicos de nanopartículas de prata 
revestidas com polivinilpirrolidona. Para isso, usou-se uma linha celular de 
epitélio pulmonar, A549, que foi exposta a concentrações crescentes de 0, 50 
e 100 µg/mL de nanopartículas de prata revestidas com PVP, de 10 e 20 nm, 
durante 24h. O teste dos micronúcleos por bloqueio da citocinese e o ensaio 
de cometas foram usados para avaliar os potenciais efeitos genotóxicos das 
nanopartículas de prata. Para validação do teste dos micronúcleos por 
bloqueio da citocinese, uma linha celular de osso, MG-63, foi exposta a 
concentrações crescentes de nanopartículas de prata revestidas com PVP, de 
20 nm. Na linha celular A549, o ensaio de cometas revelou um aumento do 
dano no DNA com o aumento da concentração de nanopartículas de 10 nm. 
Por outro lado, os resultados obtidos para as nanoparticulas de 20 nm 
mostraram um aumento significativo da degradação do DNA apenas para a 
concentração mais baixa (50 µg/mL). O teste dos micronúcleos mostrou um 
efeito citostático das nanopartículas de prata. Na linha celular MG-63 
verificou-se um aumento de micronúcleos e protusões nucleares para a 
concentração de 50 ug/mL, indicando a presença de dano no DNA. Em 
conjunto, os resultados sugerem que as nanopartículas de prata revestidas 
com PVP têm potencial para provocar dano no DNA, dependente da sua 
concentração e do seu tamanho, e têm um efeito citostático nas células.  
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
keywords 
 
AgNP; A549; MG-63; genotoxicity; comet assay; cytokinesis-block 
micronucleus cytome assay; cytostatic effect; DNA damage 
 
abstract 
 
Silver nanoparticles have increased importance due to their antimicrobial 
activity, being used in several applications such as in prosthesis, medical 
devices, food storing and cosmetics. Its increasing manufacturing will reflect in 
the environment, as for instance in the air, exposing the organism to its 
potential harmful effects. Altogether, the aim of this work was to evaluate the 
potential genotoxic effects of polyvinylpyrrolidone coated AgNPs. For that, a 
human alveolar adenocarcinoma cell line, A549, was exposed to increased 
concentrations of 0, 50 and 100 µg/mL PVP coated silver nanoparticles, of 10 
and 20 nm, for 24h. Both the cytokinesis-block micronucleus cytome assay and 
the comet assay were used to evaluate the potential genotoxic effects of silver 
nanoparticles. To validate the cytokinesis-block micronucleus cytome assay, a 
human bone cell line, MG-63, was exposed to increased concentrations of 20 
nm PVP coated silver nanoparticles. In A549 cell line, the comet assay revealed 
an increase in DNA damage, with increase concentration of silver 
nanoparticles of 10 nm. By other hand, for 20 nm AgNPs a significant increase 
in DNA damage was observed only for the lowest concentration (50 µg/mL). 
The cytokinesis-block micronucleus cytome assay showed a cytostatic effect of 
silver nanoparticles. In MG-63 cell line it was observed an increase in both 
micronucleus and nuclear buds for 50 µg/mL, indicating the presence of DNA 
damage. Altogether, the results suggest that PVP coated silver nanoparticles 
have the potential to induce DNA damage, dependent on the concentration 
and the size, and have a cytostatic effect on cells.  
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1. Introduction 
1.1. Historical overview  
Nanotechnology study and works at the atom and molecular stage, and is considered, 
by the US Government’s National Nanotechnology Initiative, “the understanding and 
control of matter at dimensions of roughly 1 to 100 nanometers, where unique 
phenomena enable novel applications.” Its applications can across several science fields, 
such as engineering, materials science, physics, chemistry and biology (please see: 
http://www.nano.gov/ and 
http://www.nanotechproject.org/topics/nano101/introduction_to_nanotechnology/). 
Although it is considered a modern science, there are records dating the 9th century of 
the use of nanomaterials (use of alternate-sized gold and silver particles by artisans of 
Mesopotamia to generate a sparkling effect to pots) [1]. By the year of 1857, Michael 
Faraday in “Experimental relations of gold (and other metals) to light” presented the first 
scientific description of the properties of nanoparticles [2]. In 1959, at an American 
Physical Society meeting at the California Institute of Technology, Richard Feynman gave 
the first talk about ideas and concepts behind nanoscience, entitled “There’s plenty of 
space at the bottom”. Only in 1974, however, the term nanotechnology was coined, by 
Professor Noro Taniguchi (please see 
http://www.nanotechproject.org/topics/nano101/introduction_to_nanotechnology/). 
Meanwhile, in the 1950’s and 1960’s, was held an enormous progress in the field of drug 
delivery by nanoparticles. One of the pioneers in this progress was Professor Peter Paul 
Speiser, which developed the first nanoparticle for drug delivery purpose and for vaccines 
[3]. In the early 1980’s, with the development of new microscopes, the modern 
nanotechnology began, and in 1981 was published the first paper about it by K. Eric 
Drexler entitled “An approach to the development of general capabilities for molecular 
manipulation” [1]. With all the development made thenceforth, in the early 2000’s start 
to appear the first consumer products that make use of nanotechnology in the market 
place (please see 
http://www.nanotechproject.org/topics/nano101/introduction_to_nanotechnology/). 
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Working at the nanoscale makes possible to scientists to use the unique physical, 
chemical, magnetic, optical and electric properties of nanomaterials, using them in a 
variety of applications such in sunscreens, in therapeutics as antimicrobian, in electronic 
devices and others. It is estimated, by the Lux Research, that by 2014 $2.6 trillion 
manufactured products will incorporate nanotechnology (please see 
http://www.nano.gov/).  
Due to the special characteristics of nanomaterials, concern has arisen about the 
impact in human health and environment, becoming important to carry out studies about 
their toxicity [4,5].  
1.2. Nanoparticles characterization and occurrence 
 Nanoparticles, (where the prefix “nano” is derived from the Greek “nanos” 
meaning “dwarf”) are particles with dimensions between 1-100 nm in one or more 
dimensions [6,7] . Due to its nano size, these particles have several unique properties, 
compared with their bulk materials, including large surface area per unit mass (which 
combined with the nano sized, increase their potential to cross cell membranes), high 
chemical reactivity (because of the larger surface area, the chemical reactivity is 
enhanced about 1000-fold) and high internal pore volumes [6,8].   
Nanoparticles can occur due to natural processes (like photochemical reactions, 
volcanic eruptions, forest fires, erosion and by plants and animals) and anthropogenic 
sources (like engineered nanomaterials, and from by-products of combustion, food 
cooking, chemical manufacturing, combustion in vehicle and airplane engines and others) 
[6,8,9]. Also, due to the increasing use of nanomaterials, in the future one possible source 
of nanoparticles would be by the co-products of incinerated nanomaterials [10].  
1.3. Classification 
 There are several aspects of nanoparticles that are important in their toxicity, like 
dimensionality, morphology, composition, uniformity and agglomeration, which are used 
to classify them. Regarding to  the number of dimensions, they can be classified in one 
dimensional (1D), two dimensional (2D) or three dimensional (3D) nanoparticles (Fig.1A) 
[6]. Morphologically, nanoparticles can be divided in high- and low-aspect ratio (having in 
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account flatness, sphericity and aspect ratio) (Fig.1B) [6]. Based on composition, 
nanoparticles can be composed of a single material or be a composite of several materials 
(Fig.1C), the first ones synthesized and the second ones more present in nature [6]. 
Relatively to uniformity and agglomeration, and having in account the chemistry and the 
electro-magnetic properties of nanoparticles, they can exist as dispersed aerosols, as 
suspensions/colloids or in an agglomerate state (Fig.1D) [6]. To prevent this agglomerate 
state, and like that maintain the characteristics of nanoparticles, sometimes they are 
stabilized with coatings [5].  
 
Fig. 1 Nanoparticles classification, having in account dimensionality (A), morphology (B), composition (C), 
uniformity and agglomeration state (D). Adapted from [6] 
 
Despite the several existing classifications, according to EPA (please see 
http://www.epa.gov/fedfac/pdf/emerging_contaminants_nanomaterials.pdf) one can be: 
 Carbon-based nanomaterials: composed mostly of carbon, with several electronic 
and biomedical applications. One example is the C60 fullerene; 
 Metal-based materials: include quantum dots, nanogold, nanosilver and metal 
oxides (e.g. titanium dioxide). Have applications in drug release, remediation, as a 
UV blocker and in medical imaging; 
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 Dendrimers: nanosized polymers built from branched units, used for drug delivery, 
DNA transferring agents, among others; 
 Composites: combination of two nanoparticles or nanoparticle with larger bulk 
type materials (an example of a bio-inorganic composite is a titanium molecule 
with DNA strands attached). Have important applications in drug delivery, cancer 
detection and to enhance mechanical and flame retardant properties in auto parts 
and packaging materials.  
1.3.1. Applications  
Due to its special characteristics, nanoparticles have a number of applications that 
cross a wide range of fields, from engineering to medicine or environmental sciences. 
Nanoparticles can be used in electronics, in transportation and telecommunication 
(nanoparticles of carbon black), in imaging (single-walled carbon nanotubes used as probe 
tips for atomic-force microscopy imaging of antibodies), in medical applications (like drug 
delivery, diagnostics and medical devices),  in pollution remediation (due to their 
enhanced chemical activity), in cosmetics (like titanium dioxide and zinc oxide), in 
coatings (to provide antimicrobial characteristics, for example), in materials such as paint, 
in mechanical engineering and in food products [1,5,6]. 
1.4. Nanotoxicology 
  With the enormous potential that nanoparticles have, and since they are present 
in almost everything of our daily life, concerns must be taken considering the statement 
that all technology comes with a price. 
There are several organs in constant contact with both engineered and natural 
nanoparticles, as skin, lungs and the gastro-intestinal tract. These are the most probable 
points of entrance to the organisms. Once inside the organism, and due to their small 
size, they can entry the cells and interact with the organelles [6]. This interaction may be 
beneficial, but may also be deleterious. Many studies have been done to understand the 
interaction between nanoparticles and cells, and several ones show a toxic effect to the 
organism. Li et al. [11] showed that lead sulfide nanoparticles (PbSNPs) induce oxidative 
damage in lung tissue. In the same tissue, Liu et al. [12] described that gold nanoparticles 
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(AuNPs) induce apoptosis and necrosis. Alarifis et al. showed that both copper oxide 
nanoparticles (CuONPs) [13] and zinc oxide nanoparticles (ZnONPs) [14] (in HaCat and 
A375 cell lines respectively), induce apoptosis and necrosis, and DNA damage mediated 
by oxidative stress. This type of DNA damage was also described by Ahamed et al. [15] in 
A431 and A549 cell lines induced by iron oxide nanoparticles (Fe3O4NPs).    
Altogether, it is important to know and understand how nanoparticles interact with 
the organism, to better realize if the positive effects are greater than the negative ones. 
1.5. Silver nanoparticles  
 Silver (Ag) is a shiny and white metallic element with number 47 in the periodic 
chart, with an atomic weight of 107.868 g mol-1, a density of 10.49 g ml-1 and a valence of 
+1 or +2. With an occurrence of 0.1 ppm in earth’s crust, it is a rare element known since 
ages, with applications in jewelry, utensils, monetary currency, dental alloy, photography, 
explosives etc. [16,17]. Ag compounds and ions have an important antimicrobial effect, 
used for both hygienic and healing purposes (dental work, catheters and burn wound for 
example) [16,18]. With the arise of manufactured silver nanomaterials, novel applications 
emerged, since they are considered to be more active due to their large surface area to 
volume ratio [19,20].  
Silver nanoparticles (AgNPs), like other types of nanoparticles, are mostly smaller 
than 100 nm and contain 20-15,000 silver atoms [19]. Among the commercialized 
nanomaterials, AgNPs are the most used nanocompounds, predicted to be incorporated 
in approximately 25% of the products [21]. This huge interest in AgNPs is due to be an 
attractive material, that can be used in several fields for catalytic, optoelectronic, sensing 
and biotechnological applications [22]. Due to their unique antibacterial, antiviral and 
antifungal properties, AgNPs are being used in several clinical applications such as in 
surgery, in wound therapy and as an anti-inflammatory, and also in consumer products 
like in food storage materials, refrigerator surfaces, disinfectants, deodorants, in water 
purification, in toothpaste, shampoo, industrial products, kitchen utensils, toys, textiles 
and humidifiers [19,23–25]. Beyond that, AgNPs are used as a drug delivery vehicle, as 
biosensor, as an imaging contracts agent [26,27] and in the treatment of diseases that 
require targeting of specific cells or organs [26]. For instance, AgNPs have been shown to 
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interact with several viruses like HIV-1 [28] hepatitis B [29], respiratory syncytial virus 
[29], herpes simplex virus type 1 [30] and monkey pox virus [31].  
With the range of applications of AgNPs there is high probability of getting 
exposed intentionally or not, to them. Therefore, information about their toxicity to 
biological systems, as is still not fully understood, should be a major concern. 
1.5.1. Toxicity of AgNPs  
In recent years several studies have emerged that establish new insights about AgNPs 
toxicity. Due to their small size, once they enter into the systemic circulation, they can 
easily migrate to other organs and tissues, like liver, spleen, lungs, kidneys and brain, 
where they can induce toxicity [22].The mechanism of uptake of AgNPs is still not clear, 
and several factors can influence it, like the morphology of nanoparticle, size, 
concentration, surface properties and the type of cell (different cells may have different 
mechanisms of uptake) [32]. Several studies found that the uptake usually happens by 
lipid raft-dependent endocytosis (caveolin-dependent), phagocytosis, clathrin-dependent 
endocytosis and macropinocytosis, the last two ones the most frequent [22,33,34]. 
 Once inside the cell, the mechanism of toxicity may involve depletion of glutathione 
(GSH), increase of reactive oxygen species (ROS), reduction of the superoxide dismutase 
(SOD) enzyme activity and increase in lipid peroxidation [35–37]. All these factors lead to 
oxidative stress in the cell, which in mitochondria can lead to disruption of the 
mitochondrial respiratory chain and interruption of ATP synthesis. The oxidative stress 
can also lead to induction of DNA damage and finally to induction of apoptosis or necrosis 
[38,39]. AgNPs are also related with disturbances in cell cycle progression and induction 
of changes in gene expression, especially in the oxidative stress related genes [40,41].  
As the mechanism of nanoparticle uptake, the outcome toxicity can be influenced by 
several factors like the size, the capability of agglomeration, the synthesis method and 
the surface chemistry of AgNPs, as well as the type of cell line. Regarding the nanoparticle 
size, studies showed that the smaller the nanoparticle, the higher the toxicity. That was 
verified in several cell lines, like in CaCo-2, where peptide-coated AgNPs of 20 nm induce 
more toxicity than the ones of 40 nm [42], and in cell lines 291.03C and RAW 264.7, 
where only the smaller nanoparticles were able to induce ROS [43]. In DC2.4, 3 nm 
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nanoparticles were able to induce toxicity at a concentration as low as 1 µg/mL [44]. 
However, it must be take into consideration, that different surface chemistries may also 
influence toxicity. Lin et al. [45] showed, that in HepG2 cell line, AgNPs stabilized with 
Poly(styrene-co-maleic anhydride)-grafting poly(oxyalkylene) (SMA) were less cytotoxic 
(despite being the smaller ones) than the ones stabilized with Poly(oxyethylene)-
segmented imide (POEM) and Poly(vinyl alcohol) (PVA). Also, Sur et al. [21] showed that 
in HDF cell line, citrate reduced AgNPs (C-AgNPs) were more toxic than the modified ones 
with lactose (L-AgNPs) or a 12-base long oligonucleotide (O-AgNPs), and Kaur et al. [46] 
that AgNPs reduced with tannic acid (TSNPs) were more toxic than the ones reduced with 
sodium borohydride (BSNPs) (with the same sizes) in A431 and RAW 264.7 cell lines.  
Beyond the importance of the nanoparticles characteristics, the cell line specificity 
is also important to consider, since the level of sensitivity may vary between cell lines. 
Studies realized with starch-coated AgNPs (6-20 nm) in IMR-90 and U251 cell lines, 
showed that the toxicity was more prominent in U251 [38]. In RAW 264.7, A498, HepG2 
and Neuro2A cell lines, the toxicity was evaluated for 40 nm AgNPs, and it was observed 
that the cell lines A498 and RAW 264.7 were more sensitive, showing toxic effects already 
for 1 or 3 µg/mL, respectively [22]. 
In many studies, isolated AgNPs or aggregations inside the cell were observed, 
specifically in the cytoplasm, inside lysosomes, nucleus and inside mitochondria [22,47]. 
The uptake of AgNPs inside the nucleus is of huge interest, because once there, they can 
interact directly with the DNA, and induce damage (in addition to the induced by the 
generation of oxidative stress). In fact, consequences like G2/M arrest, S-phase arrest and 
DNA damage was described in several studies [38,47–49]. 
Beyond the AgNPs, the silver ions (Ag+ ions) released from them also play an 
important role in the toxicity mechanism, being considered, by some authors, more toxic 
than the AgNPs themselves [38]. Beer et al. [50] described that the toxicity of AgNP 
suspension depends strongly in the initial amount of silver ions, in A549 cells, whereas 
Kim et al. [51] described that AgNPs exhibited cytotoxicity with the same potency that 
silver ions in HepG2 cells. These controversies results justify the importance of evaluate 
the amount of silver ions within the investigated AgNP suspensions.  
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Looking at recent studies done in A549 cell line, almost all the sizes of AgNPs used are 
large (above 30 nm), and almost all concerned in the cytotoxicity evaluation. This study 
concerns, thereby, in the evaluation of the genotoxic effects of smaller nanoparticles, of 
10 and 20 nm.  
1.6. Genotoxicity assessment  
 The genomic DNA is constantly under threat, and sometimes suffers damage that 
can be caused by factors as exposure to chemicals, nutrition or cellular processes such as 
action of endogenous ROS and stochastic errors in replication or recombination [52,53]. 
The alterations in the genetic material (genotoxicity) are one of the examples of cellular 
toxicity, and since they are highly correlated with an increased risk of cancer, is very 
important that they are assessed [4]. Two important tests used to determine genotoxicity 
are the comet assay and the cytokinesis-block micronucleus cytome assay [4,54]. 
1.6.1. Comet assay 
The comet assay, or single-cell gel electrophoresis, was first described and 
developed by Östling and Johanson in 1984 [55], with the migration of DNA from single 
cells in a microgel. In 1988, Singh et al. [56] developed the current and most commonly 
used variation: the alkaline comet assay.  
The comet assay combines the simplicity of biochemical techniques for detecting 
DNA single strand breaks, alkali labile sites and cross-linking, with the single cell approach 
typical of cytogenetic assays [57,58].  It is based on the ability of negatively charged 
loops/fragments of DNA to migrate out of the cell in the direction of the anode, under 
electrophoretic conditions [57,59].  When viewed under a microscope, the cells get the 
appearance of a ‘comet’, with a head (nuclear region) and a tail containing DNA 
fragments (Fig.2). 
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Fig. 2 Illustrative image of a cell after the performance of the comet assay, viewed under a microscope, 
showing its typical appearance.   
 
The size and the shape of the comet, and the distribution of the DNA within the 
comet, correlate with the extent of DNA damage [59]. The damage is posteriorly assessed 
by visual scoring (based on the tail length and the shape, the comets are classified 
qualitatively in five categories) or using a software of image analysis, that recognizes the 
extension of the damage. When using the software analysis, several parameters are 
measured, being the most relevant the % tail DNA, tail length and tail moment [57].  
 The comet assay has been widely used in research by investigators, and compared 
with other genotoxicity assays has several advantages as: (1) analyses at the level of the 
individual cell, (2) requirement for small number of cells per sample, (3) sensitivity for 
detecting low levels of DNA damage, (4) use of any eukaryote single cell population, (5) 
flexibility, (6) low costs, (7) easiness and quickness [60,61], and the detection of many 
kinds of damage by the use of repair enzimes [62] 
1.6.2. Cytokinesis-block micronucleus cytome assay 
 The cytokinesis-block micronucleus cytome assay (CBMN cyt assay) is 
recommended as an in vitro genotoxicity testing method to characterize the genotoxicity 
of nanoparticles [63,64].  This test allows the measurement of DNA damage, cytostasis 
and cytotoxicity (Fig.3) [65]. In the CBMN cyt assay, the cytokinesis is blocked in cells that 
have completed one nuclear division by the addition of cytochalasin-B (Cyt-B). Cyt-B is an 
inhibitor of actin polymerization of the microfilament ring, required for the completion of 
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cytokinesis. By that, its use enables the accumulation of once-divided cells, recognized by 
their BN appearance [64,65].  
DNA damage is measured in once-divided binucleated (BN) cells by scoring of 
micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs). MNi are 
expressed in dividing cells, and can be originated by acentric fragments (chromosome 
fragments lacking a centromere) or whole chromosomes that are unable to migrate to 
the spindle poles during anaphase [66].  NPBs are biomarkers of DNA misrepair and/or 
telomere end-fusions. They can occur between nuclei in binucleated cells and are 
probably dicentric chromosomes in which the two centromeres were pulled to opposite 
poles of the cell and the DNA in the resulting bridge is covered by nuclear membrane 
[65,66]. NBUDs are biomarkers of elimination of amplified DNA and/or DNA repair 
complexes. NBUDs are characterized by having the same morphology as an MN with the 
exception that they are linked to the nucleus by a narrow or wide stalk of nucleoplasmic 
material [65]. Cytostasis is measured via the proportion of mono-, bi-, and multinucleated 
cells and cytotoxicity via necrotic and/or apoptotic cell ratios [65].  
 
Fig. 3 Schematic figure of the cytokinesis-block micronucleus cytome assay (CBMN cyt assay), used to test 
the genotoxicity of nanoparticles. After the genotoxic event, the DNA damage is measured in once-
divided binucleated cells by scoring NPBs, MNi and NBUDs. The test also allows the measurement of 
cytotoxicity via apoptotic and/or necrotic cell ratios. Adapted from  Fenech [65]. 
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1.7. Cell line – A549  
The lungs are organs extensively exposed to AgNPs, related to one possible route of 
exposure – inhalation [4,67], being important to understand its interaction with silver 
nanoparticles.  For that, the in vitro cell model used in this study was A549 (human 
alveolar adenocarcinoma cell line).  
A549 cell line was established in 1972 and is derived from human lung 
adenocarcinoma. These cells exhibit characteristic features of Type II cells of the 
pulmonary epithelium, such as growth as an adherent monolayer, presence of 
multilamellar cytoplasmic inclusions bodies and synthesis of lecithin with high percentage 
of disaturated fatty acids [68,69].  
1.8. Aims 
Although the wide usage of AgNPs with purposes of antimicrobial activity or drug 
delivery, studies concerning their genotoxicity are still scarce. This study aimed the 
evaluation of the genotoxic effects of polyvinylpyrrolidone (PVP) coated AgNPs of two 
different sizes (10 and 20 nm) in a human lung cell line – A549. The cell line was cultivated 
in vitro and exposed to increased concentrations of PVP coated AgNPs and genotoxicity 
was later assessed by the comet assay and the CBMN cyt assay.  
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2. Materials and methods 
2.1. A549 Human alveolar adenocarcinoma cell line and MG-63 cell line cultures 
The human cell line A549 was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
A549 cell line was cultured in vitro in a controlled humid atmosphere of 5% CO2 at 37°C, 
under aseptic conditions ensured by working on a laminar flow biological safety cabinet. 
Cells were cultured in 75 cm2 culture flasks (Corning®), with 10 mL of complete growth 
medium. The complete growth medium was composed of Kaighn's Modification of Ham's 
F-12 Medium (F-12K), supplemented with 10% (v/v) Fetal Bovine Serum (FBS), 10000 
units ml-1 of penicillin-streptomycin and 2.5 μg/ml of Fungizone, all purchased from Life 
Technologies (Carlsbad, CA, USA). Before cells reach approximately 80% confluence, 
(percentage of cell coverage on the surface area of the culture vessel), which happens 
approximately every three days, they were subcultured.   
The culture conditions of MG-63 cell line were equivalent to the culture conditions of 
A549 cell line, with the exception of the complete growth medium: in A549 the complete 
growth medium was composed of Kaighn's Modification of Ham's F-12 Medium (F-12K) 
with the described supplementations, while in MG-63 was composed of α-MEM – 
Minimum Essential Medium (Gibco), with the same described supplementations,  
2.2. Trypsinization 
In order to subculture both A549 and MG-63 cells, a proteolytic enzyme (trypsin) was 
added, so that the cell-to-cell and cell-culture vessel adhesions can be digested. Before 
subculture, cells were observed under an inverted microscope to verify confluence, 
morphology and presence of contaminants. After removing culture medium, cells were 
washed with sterile phosphate buffer saline (PBS) at pH 7.2, purchased from Life 
Technologies (Carlsbad, CA, USA). Next, cells were incubated for 5 minutes at 37°C with 
0.25% trypsin/1mM EDTA purchased from Life Technologies (Carlsbad, CA, USA), and 
complete detachment and dissociation was verified under microscope. At that time, 
complete growth medium was added (2x the trypsin volume added to cells) to inactivate 
trypsin action. After cell resuspension and determination of cell density (using a 
Neubauer chamber), complete growth medium and cell suspension (on a proportion of 
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1:9 – cell suspension: complete growth medium) were added to a new culture flask 
properly identified (with cell passage, cell type, username and date).  
2.3. AgNP Exposure 
The AgNPs used in this study were spherical, well defined sizes particles of 10 and 20 
nm, coated with Polyvinylpyrrolidone (PVP) (BioPure - 1.0 mg/ml), obtained from 
NanoComposix (San Diego, CA, USA). In order to obtain the desired dilutions, the stock 
solution was diluted in complete growth medium (F12K) and sonicated for 20 minutes. 
Cells were subcultured to multiwell plates and incubated for 24h in the normal culture 
conditions for adherence. After that time, the culture medium was replaced by the same 
amount of new growth medium with the desired final dilutions of AgNPs – 0, 50, 100 
µg/mL, and cells were exposed for 24h. The final dilutions of AgNPs were chosen having 
in account the results of the cell viability test of a previous study done under the same 
conditions (Rosário, 2012, Effects of silver nanoparticles on osteosarcoma and lung cell 
lines, UA, Aveiro, Portugal). 
2.4. DNA damage 
2.4.1. Comet assay 
The comet assay was performed as described by Singh et al. [56] and Tice et al. 
[70] with slight modifications. Slides with frosted ends were dipped into a solution of 1% 
normal melting point (NMP) agarose and the dried overnight at room temperature. After 
exposure ending, cells were harvested, counted in Neubauer chamber and then 
transferred to microtubes. Cells were then centrifuged at 700 g for 5 minutes at 4ºC. The 
supernatant was removed, the pellet dispersed in PBS and centrifuged again. After the 
last centrifugation, the supernatant was removed and the pellet was dispersed in PBS 
having into account that the cellular density should be such that each gel contains 
approximately 2x104 cells. For positive control, cells were incubated with 100 µM H2O2 
exactly for 10 minutes. For that, they were centrifuged for 5 minutes and right before the 
end of 10 minutes of the H2O2 treatment, they were resuspended in PBS.  On each slide 
with the dried NPM agarose layer were spread two gels, consisting in a mixture of 50 µL 
of the cell suspension and 50 µL of 1% low melting point (LMP) agarose previously heated 
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at 37 ºC.A coverslip was placed over each mixture and the agarose was allowed to solidify 
at 4°C for at least 10 minutes. Cells were then lised in a solution containing 2.5 M NaCl, 
100 mM Na2EDTA, 10mM Trizma Base, 10 M NaHO, corrected pH 10, and 2% Triton X-
100. Coverslips were removed and cells were then treated with lysis solution for 1h30. 
Meanwhile, electrophoresis buffer was freshly prepared with chilled distilled water and 
with 10 mM NaOH and 200 mM Na2EDTA, pH 13. The reaction of lysis was stopped by 
placing slides on cold plate on ice and then the slides were immersed in an 
electrophoresis box with the cold electrophoretic buffer for 20 minutes (to allow DNA 
unwinding). Thereafter, electrophoresis ran for 30 minutes, 0.8 V/cm, 300 mA. Since 
lysing step until the end of electrophoresis, slides were kept in the dark avoiding direct 
fluorescent light to cause DNA damage. Next, slides were neutralized by rinsing in 1% PBS 
at 4°C, twice for 10 minutes. Slides were left overnight to dry. To perform comet scoring, 
the slides were rehydrated for 30 minutes with cold dH20 and stained with 20 µg/mL 
ethidium bromide for 20 minutes, removing the excess with cold dH20. Slides were 
observed under a fluorescence microscope Nikon Eclipse 80i equipped with an excitation 
filter of 510-560 nm and a barrier filter of 590 nm.  For each treatment group, one slide 
(with two gels) from each well was screened and 50-100 randomly visualized nucleoids 
were picked. Images were captured with imaging software (NIS-Elements F 3.00, SP7). 
Each image was run on version 1.2.2 of CASPLab – Comet Assay Software Project to 
automatically score a comprehensive set of parameters such as % tail DNA, tail length and 
tail moment, to provide a global comet description. 
2.4.2. Cytokinesis-block micronucleus cytome assay 
 The cytokinesis-block micronucleus cytome assay was performed as described by 
Fenech [65] with slight modifications. Cells were seeded in 6 well-plates, using one 
coverslip per well. After 24h of cell adhesion, cells were exposed to AgNPs and to 25 
µg/mL of methyl methanosulfonate (MMS) as positive control. After exposure, 
cytochalasin B (4.5 µg/mL) was added to each well and let incubate for 29 h. Cells were 
then fixed with absolute methanol cooled at 4°C. The coverslips were collected from the 
wells, properly identified and stored. To analyze micronuclei, the coverslip was stained 
with 1% acridine orange and mounted with cold distilled water. Slides were observed 
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under a fluorescence microscope Nikon Eclipse 80i equipped with an excitation filter of 
450-490 nm and a barrier filter of 520 nm. To obtain the nuclear division index, the 
number of viable cells with one, two, three or four nuclei were count in at least 500 cells 
per slide. The number of necrotic and apoptotic cells was also scored in 500 cells per 
slide. To detect and count MNi, NPBs and NBUDs a minimum of 1000 binucleated cells 
were scored per slide.  
2.5. Statistical Analysis 
All data are expressed as mean ± standard deviation (SD). The statistical analysis was 
performed using SigmaPlot for Windows version 11.0 (Systat Software Inc., San Jose, CA, 
USA).  
The assessment of statistical significance between control and AgNP-treated groups 
was performed using one-way or two-way analysis of variance (ANOVA) followed by post-
hoc testing (Tukey test) whenever significant differences were found. When the normality 
and homoscedasticity failed, a Kruskal-Wallis One Way Analysis of Variance on Ranks was 
performed (when comparing NP concentrations) or the Mann-Whitney Rank Sum test 
when only two groups were involved (i.e. when comparing NP sizes). All statistical tests 
used a level of significance of 0.05. 
Comet data, prior to statistical analysis, was normalized relative to control. Thus, both 
tail length and tail DNA were transformed as 
, 
where Tailrelative represents the normalized variable (tail length or tail DNA), Tailctrl is the 
average response in the control and Tailtreat is the measured response in the treatment. 
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3. Results and discussion  
3.1. Cell morphology and confluence 
 Cells were daily observed under an inverted microscope to check confluence, 
putative contaminations and morphology.   
 
Fig. 4 Light microscopy images of A549 cells exposed to AgNPs for 24h: A, A’ - control; B, B’ -50 µg/mL; C, 
C’ – 100 µg/mL. 
 After exposure of cells to AgNPs, for both sizes was noticed a decrease in 
confluence (number of cells) and a change in shape and morphology of cells. In control 
group, A549 cells presented a typical cuboidal epithelial aspect, which is indicative of type 
II pulmonary morphology, and colonized all the space available, after the 24h treatment 
(Fig.4A and A’). When exposed to AgNPs, cells appeared with an irregular aspect, most of 
them fusiform, and with less contacts with the neighbors. Similar results were also 
described by Lee et al. [71], also in A549 cells treated with AgNPs. Also, in AgNPs exposed 
cells the confluence was much lower comparatively to the control, realized by the space 
available in the end of the 24h treatment (Fig.4 B, B’, C and C’). These observations are 
probably related with an unhealthy status of the cells and are markedly visible even for 
the lowest concentration (50 µg/mL). These results may suggest disturbances of 
cytoskeletal functions caused by AgNPs, already questioned by Asharani et al. [38]. Other 
50µm 
50µm 
50µm 50µm 
50µm 50µm 
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groups also described similar effects in other cell lines and nanoparticles, like described 
for A375 cell line treated with ZnONPs [14].  
Dark clumps of AgNPs adsorbed on the cell surface were also seen, after treatment 
with AgNPs. For both 10 and 20 nm AgNPs, in the 50 µg/mL group, the results were 
equivalent, with some dark clumps existing (Fig.4B and B’). For the 100 µg/mL group, 
however, markedly differences could be observed when comparing 10 and 20 nm AgNPs. 
For 20 nm AgNPs, only a small difference exists in the dark clumps in 100 µg/mL 
compared to the lower concentration (Fig.4C’), but for 10 nm AgNPs was possible to see a 
markedly increase in the existing dark clumps (Fig.4C). This observations are somehow in 
agreement with a previous study done in the same conditions, where Rosário (Rosário, 
2012, Effects of silver nanoparticles on osteosarcoma and lung cell lines, UA, Aveiro, 
Portugal) described, with the Dynamic Light Sacttering (DLS) test, that for 20 nm AgNPs 
the hydrodynamic diameter (nm) decreases from 93.93 (for 50 µg/mL) to 48.04 (for 100 
µg/mL) and for 10 nm AgNPs the hydrodynamic diameter increases from 47.85 (for 50 
µg/mL ) to 84.05 (for 100 µg/mL). That can suggest that the AgNPs of 10 nm may have 
more tendency to aggregate than the ones of 20 nm, maybe due to fact that smaller 
nanoparticles have larger surface area being more reactive and, therefore, interacting 
more [6,72]. Other studies also states that the behavior of aggregation increase with the 
concentration of nanoparticles [73]. 
3.2. DNA damage 
A direct consequence of DNA damage is chromosome abnormalities, like single strand 
breaks, alkali labile sites and cross-linking, that can be measured by two tests – the comet 
assay and the CBMN cyt assay.  
3.2.1. Comet assay 
The images obtained by fluorescence microscopy reflected the tendency of the 
parameters studied. For 10 nm AgNPs, it was possible to see a bigger tail as the 
concentration of AgNPs increased (from 0 to 100 µg/mL), reflecting an increase in the 
percentage of DNA on it (Fig.5).  
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Analyzing the parameter ‘Relative Tail length’ (Fig.6A), a significant difference 
between AgNPs of 10 and 20 nm (Mann-Whitney Test, T = 208.000, n1= 16, n2= 17; P = 
0.022) was observed, however the same was not seen for the parameter ‘Relative Tail 
DNA’ (Fig.6B) (Mann-Whitney Test, T = 297.000, n1= 16, n2= 16; P = 0.221). 
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Looking at the 10 nm AgNPs (Fig.6A and B), was possible to see a concentration 
dependent increase in both parameters, with the 100 µg/mL group being significantly 
different from the control group (‘Relative Tail Length’: Kruskal-Wallis test, H = 12.923, 
df=2, P = 0.002; ‘Relative Tail DNA’: Kruskal-Wallis test, H = 12.458, df=2, P = 0.002). As 
the length of the comet tail increases with the extent of the DNA damage, after exposure 
to 10 nm AgNPs, it was, therefore, possible to observe an increase in DNA damage with 
increase nanoparticle concentration. The same tendency of a concentration dependent 
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Fig. 5 Representative images obtained by fluorescence microscopy of the comet assay, for 10nm: A) 
control, B) 50 µg/mL, C) 100 µg/mL and D) positive control. 
Fig. 6 DNA damage in A549 cell line exposed to 10 and 20 nm AgNPs using the comet assay and the 
parameters Relative tail length (A) and Relative tail DNA (B). Different letters means statistic differences 
between groups (p<0.05), where a and b refers to 10 nm AgNPs, and x and y to 20 nm AgNPs. 
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increase in DNA damage was also previously described in literature. It was described that 
the cell lines U251 and IMR-90 have that tendency when treated with increased 
concentrations of AgNPs [38] and the same was described for A549 cell line when treated 
with other types of nanoparticles, like CeO2NPs [74] and MFI nanoparticles [75].   
For AgNPs of 20 nm (Fig.6A and B), the amount of DNA damage, evaluated with 
both parameters was significant only for the 50 µg/mL group (‘Relative Tail Length’: 
Kruskal-Wallis test, H = 10.283, df=2, P = 0.006; ‘Relative Tail DNA’: Kruskal-Wallis test, H 
= 11.765, df=2, P = 0.003). This result may be explained by the statement that higher sizes 
of nanoparticles, along with the behavior of agglomeration, may not be able to enter so 
easily in cells, as smaller ones [76]. A previous study done by Kruszewski et al. [77] also 
reported a slight decrease (although not significant) between the concentrations 50 and 
100 µg/mL, when A549 cells where treated with 20 nm AgNPs.  
Although the parameter “tail moment” is commonly used in many studies to 
evaluate the DNA damage [38,75,78], it has the disadvantage that there are no standard 
units (once it is the product of tail intensity x tail length), adding little information about 
the level of damage presented [79]. Therefore, it was decided not to include this 
parameter.   
3.2.2. Cytokinesis-block micronucleus cytome assay 
When performed the CBMN cyt assay, some images were taken, that represents 
well the tendency of the parameters studied (Fig.7)   
 
 
Fig. 7 Representative images obtained by fluorescence microscopy of the cytokinesis-block micronucleus 
cytome assay in A549 cells: A) binucleated cells (control), B) mononucleated cells (100 µg/mL 20 nm 
AgNPs), C) necrotic cells (50 µg/mL 20 nm AgNPs) and D) apoptotic cell (50 µg/mL 10 nm AgNPs). 
A                                  B                                   C                                 D 25µm 25µm 25µm 25µm 
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After exposure to both 10 and 20 nm AgNPs, it was observed a marked decrease 
in the number of binucleated cells (Fig.7A and Fig.8), and therefore an increase in 
mononucleated ones (Fig.7B and Fig.8), for both concentrations, when compared to 
control (statistical analysis represented in table 1 and 2). Statistical analysis showed no 
differences between AgNPs sizes.  
 
Fig. 8 Percentage of mono and binucleated cells assessed with the cytokinesis-block micronucleus cytome 
assay, after exposure of A549 cells to 10 and 20 nm AgNPs.  Results are expressed as means ± standard 
deviation. 
 
Table 1 Statistical analysis for Mononucleated cells: Two Way Analysis of Variance 
 F DF P Tukey-test 
NP Concentration 25.923 2 <0.001 [0]≠[100]=[50] 
NP Size 1.008 1 0.335 10nm=20nm 
Interaction 0.513 2 0.611  
 
 
Table 2 Statistical analysis for Binucleated cells: Two Way Analysis of Variance 
 F DF P Tukey-test 
NP Concentration 303.767 2 <0.001 [100]=[50]≠[0] 
NP Size 0.000423 1 0.984 10nm=20nm 
Interaction 0.0258 2 0.975  
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When calculated the NDI, it was observed a markedly decrease when the cells 
were treated with both 50 and 100 µg/mL of AgNPs, with no differences between AgNPs 
of 10 and 20 nm (statistics represented in table 3). This observation also reflects the large 
number of mononucleated cells, once it is far from the ideal value of 2 [65], when all the 
cells are binucleated (Fig.9). 
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Fig. 9 Nuclear division index (NDI) assessed by the cytokinesis-block micronucleus cytome assay, after 
exposure of A549 cells to 10 and 20 nm AgNPs. Results are expressed as mean ± standard deviation 
 
 
 
Table 3 Statistical analysis for the NDI: Two Way Analysis of Variance 
 F DF P Tukey-test 
NP Concentration 1179.826 2 <0.001 [100]=[50]≠[0] 
NP Size 0.00674 1 0.936 10nm=20nm 
Interaction 0.0172 2 0.983  
 
When evaluated the number of necrotic and apoptotic cells, it was seen that the 
number of cells under death was high, even in the control group, predominantly in 
necrosis (statistics represented in table 4 and table 5), having no differences between 
cells treated with 10 or 20 nm AgNPs (Fig.10). In apoptosis, the significant differences 
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occurred only between 50 µg/mL and 100 µg/mL. In necrosis, the 50 µg/mL group was 
significantly different from the control and from 100 µg/mL.  
 
 
 
 
Table 4 Statistical analysis for necrosis evaluation: Two Way Analysis of Variance 
 F DF P Tukey-test 
NP Concentration 5.979 2 0.016 [100]=[0]≠[50] 
NP Size 1.583 1 0.232 10nm=20nm 
Interaction 0.561 2 0.585  
 
Table 5 Statistical analysis for apoptosis evaluation: Two Way Analysis of Variance 
 F DF P Tukey-test 
NP Concentration 5.313 2 0.022 [50]≠[100] 
NP Size 0.0482 1 0.830 10nm=20nm 
Interaction 0.230 2 0.798  
 
 
Fig. 10 Percentage of necrotic and apoptotic cells assessed with the cytokinesis-block micronucleus 
cytome assay, after exposure of A549 cells to increasing concentrations of 10 and 20 nm AgNPs. Results 
are expressed as means ± standard deviation. 
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Taken together the previous observations, the existence of more mononucleated 
cells than binucleated ones, and the markedly reduction of the NDI after treatment with 
AgNPs, may be explained by the cytostatic effect induced by AgNPs on cells, previously 
described by other authors [80]. In fact, it was described in a previous report by Rosário 
(Rosário, 2012, Effects of silver nanoparticles on osteosarcoma and lung cell lines, UA, 
Aveiro, Portugal), that both 10 and 20 nm AgNPs induced cell cycle arrest at G2/M phase 
in A549 cell line. Although is not consensual what type of arrest AgNPs may induced, it 
was described by other authors the same tendency of an arrest at G2/M phase [71,81]. 
The cell cycle arrest at G2/M phase was described previously by some authors, to be 
related with the progression of cells to apoptosis [82,83]. Rosário (Rosário, 2012, Effects 
of silver nanoparticles on osteosarcoma and lung cell lines, UA, Aveiro, Portugal) 
described also a decrease in the number of viable A549 cells and an increase in the 
number of late apoptotic ones, in accordance to the cell cycle analysis. This tendency was 
observed, however, only for 10 nm AgNPs. Also, almost none necrotic cells were 
observed, for both sizes of AgNPs. In the present study, the number of both apoptotic and 
necrotic cells was high even in the control group. One possible explanation for these high 
baseline levels, along with the large number of mononucleated could be due to the use of 
cyt-B per se, rather than due to the AgNPs. The large number of mononucleated cells may 
be explained by a not sufficient time of exposure to cyt-B, in order to cells recover its 
cycle, and the high number of cells in cellular death, mainly in necrosis, due to a possible 
over high concentration of cyto-B, toxic to cells. 
According to Fenech [65], the scoring of the CBMN cyt assay related parameters 
MNi, NBUDs and NPBs should be performed in binucleated cells, meaning an ideal NDI 
value of 2. Since the NDI was near 1 for both concentrations of AgNPs tested, the 
requirements for measuring DNA damage were not totally accomplished in this study. In 
order to improve the test, the concentration of cyt-B and time of exposure were 
optimized. Some previous studies indicate that A549 cell line is more sensitive to lower 
concentrations of NP, when compared to other cell lines. De Marzi et al. [74] described 
that for 0.5 µg/mL of CeO2NP, A549 cell line was the most sensitive, compared to CaCo2 
and HepG2 cell lines. Furthermore, Rosário (Rosário, 2012, Effects of silver nanoparticles 
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on osteosarcoma and lung cell lines, UA, Aveiro, Portugal) compared the MG-63 and A549 
cell lines, and found that A549 was more sensitive, once the results obtained for the cell 
cycle analysis for 50 µg/mL in A549 cell line were comparable with the ones obtained for 
100 µg/mL in MG-63. Also, no significant apoptotic or necrotic cells were observed in MG-
63 cell line, whereas in A549 was significant already for 24h of AgNP treatment (Rosário, 
2012, Effects of silver nanoparticles on osteosarcoma and lung cell lines, UA, Aveiro, 
Portugal). Therefore, the osteoblast like cell line MG-63 was chosen as a less sensitive cell 
line to be a model for the optimization of the CBMN cyt assay conditions, specifically in 
what concerns to Cyt-B concentration and duration of the incubation. The MG-63 cell line 
is also an interesting model, as the bone is an organ extensively exposed to AgNPs due to 
its use in bone and dental implants, medical devices and bone cement [84].  
The CBMN cyt assay conditions used in A549 cell line, 4.5 µg/mL of cyt-B, with a 
time of exposure of 29h, were replicated in MG-63 cell line, along with 3 µg/mL of cyt-B 
(the minimum of the usually range of 3 to 6 µg/mL [64]) with a time of exposure of 35h. 
For 4.5 µg/mL of cyt-B, in both times, although the cells were binucleated, the number of 
necrotic and apoptotic cells was too high (approximately 50%). When 3 µg/mL of cyt-B 
was used the cells were healthy. Considering the duration of the exposure, when the time 
of exposure was 29h, the amount of binucleated cells was still low (around 30%), but for 
35h of exposure, almost all cells were binucleated (Table 6). Altogether, it was realized 
that the conditions 3 µg/mL of cyt-B with a time of exposure of 35h were the most 
suitable.  
Table 6 : Qualitative study with the aim of optimization of the parameters “Concentration of 
cytochalasin-B” and “time of exposure” for MG-63 cell line. The X represents the non-viable state of cells; 
the  represents the existence of healthy cells, however with a low percentage of binucleated ones; 
the represents de existence of healthy cells, almost all binucleated 
29h 35h 
[0] [3] [4.5] [0] [3] [4.5] 
  X   X 
 
After the optimization of the CBMN cyt assay conditions, the test was validated by 
exposure of MG-63 cell line to 50 and 100 µg/mL of 20 nm AgNPs. 
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Results showed that the number of binucleated cells was much higher than the 
mononucleated ones for both concentrations (Fig.11), with significant variance between 
them (Mononucleated cells: One way analysis, F2,6 = 11.090, P= 0.01; Binucleated cells: 
One way analysis, F2,6 = 94.184, P<0.001). For both mononucleated and binucleated cells, 
the control was significantly different from 50 µg/mL and 100 µg/mL. 
The NDI (Fig.12) was near the ideal value of 2 for either concentrations (Kruskal-
Wallis test: H = 2.756, DF=2, P= 0.296), therefore, it was considered that the CBMN assay 
conditions were optimized and the assay was validated for MG-63 cells line. Then the 
putative effects of AgNPs on DNA damage of MG-63 cells were evaluated. 
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Fig. 11 Percentage of mono and binucleated cells assessed with the cytokinesis-block micronucleus 
cytome assay, after exposure of MG-63 cells to increasing concentrations of 20 nm AgNPs. Results are 
expressed as means ± standard deviation. Different letters means statistic differences between groups 
(p<0.05), where a and b refers to mononucleated cells, and x and y  to binucleated cells.  
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Fig. 12 Nuclear division index assessed with the cytokinesis-block micronucleus cytome assay, after 
exposure of MG-63 cells to 20 nm AgNPs. Results are expressed as means ± standard deviation.  
A slightly increase in the number of necrotic and apoptotic cells was observed 
(Fig.13), in both concentrations, when compared to control. However, only necrosis, for 
100 µg/mL was significant (Apoptosis: One way analysis, F2,6= 4.261, P= 0.071; Necrosis: 
One way analysis, F2,6 = 5.297, P= 0.047). 
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Fig. 13 Percentage of necrotic and apoptotic cells assessed with the cytokinesis-block micronucleus 
cytome assay, after exposure of MG-63 cells to increasing concentrations of 20 nm AgNPs. Results are 
expressed as means ± standard deviation. No statistical differences were found for the apoptosis. In 
necrosis, different letters means statistic differences between groups (p<0.05).  
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The parameters for the evaluation of the DNA damage, MNI, NBUDs and NPBs 
were then scored, and some representative images were taken (Fig.14), to better 
elucidate their morphologies.   
 
 
When evaluated the parameters (Fig.15), it was observed that all the three 
followed the same tendency, increasing for 50 µg/mL, and decreasing for 100 µg/mL. For 
the MNi (Kruskal-Wallis test: H = 7.200, DF=2, P=0.004) and the NBUDs (Kruskal-Wallis 
test: H = 7.261, DF=2, P=0.004) the increase for 50 µg/mL was significant, however, the 
same was not observed for the NPBs (Kruskal-Wallis test: H = 5.445, DF=2, P= 0.071). 
Regarding the behavior for 100 µg/mL, it may be explained by the fact that when the 
concentration of AgNPs increase, the behavior of aggregation would also increase [73]. A 
consequence of that aggregation behavior would be the reducing of the surface area of 
AgNPs, to which the cells may be exposed, probably decreasing their toxicity.  However, 
in a previous study by Rosário (Rosário, 2012, Effects of silver nanoparticles on 
osteosarcoma and lung cell lines, UA, Aveiro, Portugal), was found that 20 nm AgNPs 
diluted in α-MEM (the medium in which MG-63 cells were cultured) had a less tendency 
to aggregate, comparing to the ones diluted in F-12K, justifying the need of a careful 
characterization, and suggesting other ways of action of the AgNPs.  
25µm 25µm 25µm 25µm 
A                                B                               C                           D 
Fig. 14 Representative images obtained by fluorescence microscopy of the cytokinesis-block micronucleus 
cytome assay in MG-63 cells for 20 nm AgNPs: A) binucleated cells (control), B) binucelated cell with two 
micronuclei (50 µg/mL), C) binucleated cell with two nucleoplasmic bridges (50 µg/mL) and D) 
binucleated cell with one nuclear bud (50 µg/mL).  
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Fig. 15 Assessed parameters with the cytokinesis-block micronucleus cytome assay to evaluate DNA 
damage, after exposure of MG-63 cells to 20 nm AgNPs: A) Micronucleus (MNi) per 1000 binucleated 
cells; B) Nuclear buds (NBUDs) per 1000 binucleated cells and C) Nucleoplasmic bridges (NPBs) per 1000 
binucleated cells. Results are expressed as means ± standard deviation. Different letters means statistic 
differences between groups (p<0.05).  
The presence of MNi, NBUDs and NPBs in the CBMN cyt assay may be indicative of 
a large number of disturbances, affecting both the chromosomes, the spindle fiber, the 
kinetochore proteins, among others [for review see 87,88]. The huge range of anomalies 
that can exist makes difficult to study what is really originating the disturbances. 
 The damage can be due to the AgNPs itself, meaning that somehow they must 
enter to the nucleus, by the release of Ag+ ions, or also by the generation of ROS both by 
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the AgNPs and the Ag+ ions (Fig.16). In order to AgNPs interact directly with DNA, they 
must be able to diffuse into the nucleus. One possible way for that to happen is through 
the nuclear pore complexes [38]. The pores have an effective diameter of 9-10 nm, so, 10 
nm AgNPs, if not aggregated, may be able to diffuse inside the nucleus, but not 20 nm 
AgNPs, at least by this way. 
 
Fig. 16 Proposed forms of AgNPs interaction with DNA: i) direct interaction of the AgNP; ii) interaction of 
the  Ag
+
 dissolved ion; iii)  indirectly by the formed ROS. 
 
Previous reports [34] described 20 nm AgNPs inside the nucleus of A549 cells, 
meaning that may exist another possible route of entry. However, another report by 
Greulich et al. [87] described that 80 nm PVP-AgNPs were able to enter into hMSC cells, 
but not into their nuclei. Altogether, these results show that there are different ways of 
entrance of AgNPs into the nucleus, however they should be also size-dependent. Once 
inside the nucleus, AgNPs may interact directly with the DNA. In fact, a preliminary report 
by Basu et al. [88] showed the possible interaction of AgNPs with DNA bases, showing the 
preference of the interactions: C>G>A>T. However, the lack of genotoxic studies does not 
allow yet to infer how the AgNPs interact in vitro and in vivo with the DNA itself. The 
interaction can also happen by the release of Ag+ ions from AgNPs. Although it is not 
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consensual, the evidences suggest that Ag+ ion account in some part for the AgNP toxicity 
[50]. Once inside the cell, the AgNPs may release Ag+ ions, with the size of the 
nanoparticles influencing the kinetics of dissolution. The smallest nanoparticles dissolved 
faster and to a larger extent [89], and posteriorly may induce the production of ROS that 
consequently lead to oxidative stress [38]. The Ag+ ions can also diffuse inside the nucleus 
and interact directly with proteins containing –thiol groups [90]. The easier diffusion of 
smaller nanoparticles inside the nucleus, along with the larger extent of smaller 
nanoparticles, may explain the lower DNA damage with the 20 nm AgNPs in the comet 
assay.  
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4. Conclusions and future perspectives 
The present work showed the genotoxic potential of PVP coated AgNPs in two 
different cell lines, of lung and bone. In A549 cell line both sizes of AgNPs (10 and 20 nm), 
were able to induce DNA damage, with the smaller being more toxic. Also, a cytostatic 
effect induced by the AgNPs was observed. 
To our knowledge, this is the first study that shows DNA damage induced by AgNPs in 
bone cells. In MG-63 cell line the 20nm AgNPS induced both MNi and NBUDs in the lower 
concentration, indicating the presence of DNA damage. 
In future work, in order to complement the observations made with the comet assay 
for A549 cell line, and with the cytokinesis-block micronucleus cytome assay in MG-63 cell 
line, the missing assays should be performed, along with the FPG-modified comet assay. 
The quantification of dissolved Ag+ ions would be also important, together with the 
individual study of the effects made by AgNPs and by the Ag+ ions, to better understand 
which one more contributes to the toxicity.  
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